 |
| February
6, 2026 |
| Covering
Life Sciences Drugs, Diagnostics, Devices,
Digital Health |
|
|
|
* may need subscription to view |
- Coherus Oncology: Clinical Supply Agreement
to Evaluate Tagmokitug in Combination With
Pasritamig More
More*
- Denali Therapeutics: Enzyme TransportVehicle
Progress Across Three Clinical Programs for
Treatment of Lysosomal Storage Disorders at
2026 WORLDSymposium More
- Hims & Hers: Expands Personalized Weight
Loss Portfolio With Access to Compounded
Semaglutide Pills Starting at $49/Month* More
More More*
More*
- Iovance Biotherapeutics: Best-in-Class
Real-World Data Support Early Amtagvi®
Treatment in Advanced Melanoma More
- Magnus Medical: First Patient Enrolled at
University of Massachusetts in Pivotal
DoD-Funded Multisite Study of SAINT for
Postpartum Depression More
- Pulse
Biosciences: Presents Late-Breaking Data From
nPulse Cardiac Catheter System First-In-Human
Feasibility Study at the AF Symposium More
- Spruce Biosciences: Long-Term Data Presented
at the 22nd Annual WORLDSymposium Highlights
Tralesinidase Alfa Enzyme Replacement
Therapy’s Potential as the First
Disease-Modifying Treatment Option for
Sanfilippo Syndrome Type B (MPS IIIB) More
|
|
 |
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- Exclusive VC Funding Data from BYTE51,
with Special Big4Bio Pricing More
- LSN: Hot Investor Mandates (Updated 02/03) More
- More on Eikon IPO Growing to Biggest for
Biotech Since 2024, Raising Nearly $400
Million Before Falling in Debut More*
More*
More* More
|
|
 |
 |
| San
Francisco's most flexible contract
vivarium lab space: Start with a
few cages and grow. |
|
Learn More
→ |
|
|
- BioPharmGuy News: Vegas Biohazards, Mailed
Underwear, Vaccine Recommendations, Cephalopod
Lab Rat More
- Dispute Between Corcept Therapeutics, FDA
Runs Deep More*
- More on Braveheart Bio Naming Marc Evanchik
CSO More*
- Nektar Therapeutics Is Trying to Stage a
Comeback. But a Big Test Awaits
More*
- Subscribe to LifeSci Startup for
Updates on US Startups More
- The Big4Bio Podcast: Every Moment
Matters: The Power of Study Director–Advisor
Partnerships Podcast
- This
Brand-New Peninsula Building Sat Vacant for
a Year. Now It’s Landed Two Big Tenants More*
- Tony Dungy’s Son Has a Congenital Pain
Condition. Here’s What the NFL Hall of Famer
Says About It More*
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: SFBay Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
| Apply
to have your company
showcased by Big4Bio |
|
|
|
|
|
 |
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- AI in Biotech: The New Frontier for
Leadership & Strategy More
- Employers Warm Up to Remote Workers Again:
BioSpace Report More
- From Seed to Series C: What
Investors Look for Beyond the Science More
- ICYMI: CEO’s Perspective: Big Moves Come
with Big Responsibility More
- ICYMI: CEO’s Perspective: The High Cost of
Job Hopping More
- ICYMI: Elevating Executive Presence: A
Blueprint for Life Sciences and Biotech
Leaders More
- Janux Hires CMO After T Cell Engager Deal
With Bristol Myers; a Batch of Appointments at
Lexeo More*
- M&A in Life Sciences: The Turning Tide –
Why Now is a Strategic Inflection for
Biopharma and Biotech More
- The Rise of Fractional Talent in Life
Sciences: What to Expect in 2026 More
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:SFBay,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
